Recruitment

Recruitment Status
Unknown status
Estimated Enrollment
25

Inclusion Criteria

No family history of DCM
DCM diagnosed for more than two weeks without new ventricular arrhythmias or AuriculoVentricular Block (AVB) second or third degree , who responded to the usual treatment in the first two weeks of treatment
Patients with DCM as defined by the European Society of Cardiology and recognized as such by the clinician cardiologist
...
No family history of DCM
DCM diagnosed for more than two weeks without new ventricular arrhythmias or AuriculoVentricular Block (AVB) second or third degree , who responded to the usual treatment in the first two weeks of treatment
Patients with DCM as defined by the European Society of Cardiology and recognized as such by the clinician cardiologist
Absence of other causes of non-family DCM discovered during the initial etiological ( some deficiency , toxic alcoholic or drug )
Patients who underwent cardiac MRI for etiological DCM for less than four weeks at the time of obtaining consent
Affiliated to a social insurance
Patients above 18 years of age
Lake of clinical or biological cases for periphiral myopathy or myotonia
Patients who have read and understood the information letter and who signed the consent form

Exclusion Criteria

History of severe thrombocytopenia type II ( heparin induced thrombocytopenia or immuno- allergic thrombocytopenia ) , heparin or unfractionated heparin , low molecular weight
Other causes of non-family DCM discovered during the initial etiological ( some deficiency , toxic alcohol or medication , endocrine )
History of chemotherapy with anthracyclines
...
History of severe thrombocytopenia type II ( heparin induced thrombocytopenia or immuno- allergic thrombocytopenia ) , heparin or unfractionated heparin , low molecular weight
Other causes of non-family DCM discovered during the initial etiological ( some deficiency , toxic alcohol or medication , endocrine )
History of chemotherapy with anthracyclines
Minors
Eosinophilia or immuno- allergic mechanism suspected
Patients with Crohn's disease
Ischemic cardiomyopathy defined by history of myocardial infarction or myocardial revascularization , stenosis ≥ 75% of the core or the left coronary artery anterior interventricular proximal stenosis ≥ 75% on at least two epicardial vessels
History of acute myocarditis
Patients with active tuberculosis
Patients with chronic liver disease
Treatment immunosuppressive received from cardiac MRI
Significant organic valvular echocardiography
Major Trust
No affiliation to a social insurance
Family history of DCM
History of sarcoidosis
Patients with active neoplasia
Patient with signs of circulatory failure or congestive heart failure requiring intravenous positive inotropic therapy or diuretic therapy
Hypersensitivity to heparin.
Pregnant or lactating women
Patients with connective : rheumatoid arthritis , systemic lupus erythematosus , systemic sclerosis , dermato- polymyositis , mixed connective

Summary

Conditions
Patients With Idiopathic Dilated Cardiomyopathy
Type
Interventional
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Diagnostic

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

No family history of DCM
DCM diagnosed for more than two weeks without new ventricular arrhythmias or AuriculoVentricular Block (AVB) second or third degree , who responded to the usual treatment in the first two weeks of treatment
Patients with DCM as defined by the European Society of Cardiology and recognized as such by the clinician cardiologist
...
No family history of DCM
DCM diagnosed for more than two weeks without new ventricular arrhythmias or AuriculoVentricular Block (AVB) second or third degree , who responded to the usual treatment in the first two weeks of treatment
Patients with DCM as defined by the European Society of Cardiology and recognized as such by the clinician cardiologist
Absence of other causes of non-family DCM discovered during the initial etiological ( some deficiency , toxic alcoholic or drug )
Patients who underwent cardiac MRI for etiological DCM for less than four weeks at the time of obtaining consent
Affiliated to a social insurance
Patients above 18 years of age
Lake of clinical or biological cases for periphiral myopathy or myotonia
Patients who have read and understood the information letter and who signed the consent form

Exclusion Criteria

History of severe thrombocytopenia type II ( heparin induced thrombocytopenia or immuno- allergic thrombocytopenia ) , heparin or unfractionated heparin , low molecular weight
Other causes of non-family DCM discovered during the initial etiological ( some deficiency , toxic alcohol or medication , endocrine )
History of chemotherapy with anthracyclines
...
History of severe thrombocytopenia type II ( heparin induced thrombocytopenia or immuno- allergic thrombocytopenia ) , heparin or unfractionated heparin , low molecular weight
Other causes of non-family DCM discovered during the initial etiological ( some deficiency , toxic alcohol or medication , endocrine )
History of chemotherapy with anthracyclines
Minors
Eosinophilia or immuno- allergic mechanism suspected
Patients with Crohn's disease
Ischemic cardiomyopathy defined by history of myocardial infarction or myocardial revascularization , stenosis ≥ 75% of the core or the left coronary artery anterior interventricular proximal stenosis ≥ 75% on at least two epicardial vessels
History of acute myocarditis
Patients with active tuberculosis
Patients with chronic liver disease
Treatment immunosuppressive received from cardiac MRI
Significant organic valvular echocardiography
Major Trust
No affiliation to a social insurance
Family history of DCM
History of sarcoidosis
Patients with active neoplasia
Patient with signs of circulatory failure or congestive heart failure requiring intravenous positive inotropic therapy or diuretic therapy
Hypersensitivity to heparin.
Pregnant or lactating women
Patients with connective : rheumatoid arthritis , systemic lupus erythematosus , systemic sclerosis , dermato- polymyositis , mixed connective

Locations

Saint Herblain, 44805
Nantes, 44903
Saint Herblain, 44805
Nantes, 44903

Tracking Information

NCT #
NCT02078141
Collaborators
Not Provided
Investigators
  • Principal Investigator: Nicolas Piriou, MD Nantes UH
  • Nicolas Piriou, MD Nantes UH